Ilumya is used to treat moderate to severe plaque psoriasis. Tildrakizumab-asmn belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may lead to the overgrowth of skin cells and redness/swelling seen in plaque psoriasis. Tildrakizumab-asmn can help lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.
Indicated for the treatment of:
- Plaque Psoriasis
Injection Duration:
Frequency of treatment:
-
Loading Dose: Injections at 0, 4
-
Maintenance Dose: Every 12 weeks
Technology utilized for this injection
- J-Tip (Eliminates the physical pain of the IV stick)
Why people choose PURE to receive their Ilumya injection:
- Private Suites
- Comfortable power recliners
- Room for guests
- Desks to work
- High-speed wi-fi
- 55” 4K TVs
- Netflix, iPad, music
- Snacks and amenities on us
